MedPath

Sleep Timing and Energy Balance

Not Applicable
Completed
Conditions
Meals
Sleep
Interventions
Behavioral: Normal sleep
Behavioral: Late meals
Behavioral: Late sleep
Behavioral: Normal meals
Registration Number
NCT01866280
Lead Sponsor
St. Luke's-Roosevelt Hospital Center
Brief Summary

The purpose of this study is to test the effects of sleep and meal timing, independent of sleep duration, on glucose regulation and metabolic and hormonal control of energy balance in normal weight adults.

This study will be a 4-phase, randomized controlled study of 5 days each in which participants will undergo 2 phases of late sleep times that differ in meal timing (normal or late) and 2 phases of normal sleep times that differ in meal timing (normal or late).

The Aims and Hypotheses of this study are:

Aim 1: To compare hormonal regulation of food intake and metabolic risk markers in response to altered sleep and meal timing.

* Hypothesis 1: There will be an interaction between sleep and meal time on glucose, insulin, and glucose and insulin area under the curve after the glucose tolerance test such that the late sleep/late meal will result in the worst metabolic profile, normal sleep/late meal and late sleep/normal meal will have an intermediate profile, and normal sleep/normal meal will result in the best metabolic profile.

* Hypothesis 2: There will be an interaction between sleep and meal time on leptin and ghrelin concentrations such that the late sleep/late meal timing phase will result in low leptin/high ghrelin, normal sleep/late meal timing and late sleep/normal meal will have an intermediate profile, and normal sleep/normal meal timing will result in high leptin/low ghrelin.

Aim 2: To compare food intake over a 24-h period in response to altered sleep and meal timing.

• Hypothesis 3: Energy and fat intakes will be greater during the late sleep timing phase compared to normal sleep timing.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Body mass index 22-25
  • Normal scores on sleep questionnaires (PSQI, ESS, Berlin, SDIQ)
  • Normal score on Beck Depression Inventory
  • Intermediate chronotype on Composite Scale of Morningness/Eveningness
Read More
Exclusion Criteria
  • Neurological, medical, or psychiatric disorders
  • Eating disorders
  • Diabetes
  • Sleep disorders
  • Travel across time zones
  • History of drug/alcohol abuse
  • Caffeine intake >300 mg/d
  • Excessive daytime sleepiness
  • Pregnancy or within 1 y post-partum
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Normal sleep Normal mealsNormal sleepNormal sleep/Normal meal times
Normal sleep Late mealsNormal sleepNormal sleep/Late meal times
Late sleep Late mealsLate mealsLate sleep/Late meal times
Normal sleep Late mealsLate mealsNormal sleep/Late meal times
Late sleep Normal mealsLate sleepLate sleep/Normal meal times
Normal sleep Normal mealsNormal mealsNormal sleep/Normal meal times
Late sleep Late mealsLate sleepLate sleep/Late meal times
Late sleep Normal mealsNormal mealsLate sleep/Normal meal times
Primary Outcome Measures
NameTimeMethod
Oral Glucose Tolerance2 hours

Oral glucose tolerance test will be performed at scheduled breakfast time on day 4

Food intakeSingle day

Ad libitum food intake will be assessed on day 5

Meal tolerance test3 hours

Glucose and insulin responses to a liquid meal will be assessed at scheduled lunch time

Secondary Outcome Measures
NameTimeMethod
Hormonal profile24 hours

On day 3, the following hormones will be assessed from overnight hours: glucose, insulin, cortisol, melatonin, leptin, ghrelin, PYY, GLP-1

Trial Locations

Locations (1)

St. Luke's/Roosevelt Hospital

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath